Clear Labs delivers diagnostic solutions for healthcare and food safety using whole genome sequencing (WGS) and next-generation sequencing (NGS) to detect infectious disease outbreaks and to test food for safety. Its flagship Clear Dx Microbial Surveillance WGS provides an automated end-to-end sequencing system for bacterial and fungal isolates. It also offers SARS-CoV-2 surveillance and wastewater monitoring to expand its surveillance services and markets. Its goal is to enable faster, more accurate detection and monitoring of infectious diseases and foodborne pathogens to protect public health and support business growth.
Company Size
51-200
Company Stage
Series D
Total Funding
$150.2M
Headquarters
San Carlos, California
Founded
2014
See people who can refer or advise you
Help us improve and share your feedback! Did you find this helpful?